Could a diabetes pill heal scarred hearts? new trial aims to find out.
NCT ID NCT07294495
First seen Jan 05, 2026 · Last updated May 05, 2026 · Updated 19 times
Summary
This study tests whether a daily pill called henagliflozin (a diabetes drug) can reduce scarring in the heart muscle of people with a condition called non-obstructive hypertrophic cardiomyopathy, where the heart wall is thickened. About 150 adults will receive either the drug or a placebo for 6 months. The researchers will use special PET and MRI scans to measure changes in heart scarring.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HCM - HYPERTROPHIC CARDIOMYOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai East Hospital
Shanghai, Shanghai Municipality, 200120, China
Conditions
Explore the condition pages connected to this study.